We just received data on a new analyst forecast for $CLH. Jerry Revich from Wells Fargo set a price target of 220.0 for CLH.
To track analyst ratings and price targets for $CLH, check out Quiver Quantitative's $CLH forecast page.
Should you buy $CLH?
Some analysts are better than others. To view the past performance of Wells Fargo, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CLH Price Targets
Multiple analysts have issued price targets for $CLH recently. We have seen 6 analysts offer price targets for $CLH in the last 6 months, with a median target of $248.0.
Here are some recent targets:
- Jerry Revich from Wells Fargo set a target price of $220.0 on 11/14/2025
- Jon Windham from UBS set a target price of $240.0 on 10/31/2025
- Patrick Tyler Brown from Raymond James set a target price of $270.0 on 10/30/2025
- William Grippin from Barclays set a target price of $230.0 on 10/30/2025
- Noah Kaye from Oppenheimer set a target price of $256.0 on 07/31/2025
- Devin Dodge from BMO Capital set a target price of $268.0 on 07/31/2025
$CLH Congressional Stock Trading
Members of Congress have traded $CLH stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CLH stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 08/07, 06/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CLH Insider Trading Activity
$CLH insiders have traded $CLH stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CLH stock by insiders over the last 6 months:
- ALAN S MCKIM (EXEC CHAIR, CTO.) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $22,446,950.
- ERIC W GERSTENBERG (CO-CEO) sold 8,076 shares for an estimated $1,818,957
- BRIAN P WEBER (EVP (CHESI)) sold 3,035 shares for an estimated $689,460
- MICHAEL LOUIS BATTLES (CO-CEO) purchased 2,000 shares for an estimated $467,000
- JOHN R. WELCH sold 1,250 shares for an estimated $285,637
- ROBERT SPEIGHTS (PRESIDENT, INDUSTRIAL SERVICES) sold 1,022 shares for an estimated $233,516
- ALISON A. QUIRK sold 893 shares for an estimated $199,755
- ANDREA ROBERTSON sold 836 shares for an estimated $195,323
- LAUREN STATES sold 836 shares for an estimated $189,078
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLH Hedge Fund Activity
We have seen 232 institutional investors add shares of $CLH stock to their portfolio, and 313 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D1 CAPITAL PARTNERS L.P. added 1,250,615 shares (+647.9%) to their portfolio in Q2 2025, for an estimated $289,117,175
- NORDEA INVESTMENT MANAGEMENT AB added 471,206 shares (+inf%) to their portfolio in Q3 2025, for an estimated $109,423,457
- MILLENNIUM MANAGEMENT LLC removed 293,275 shares (-80.8%) from their portfolio in Q2 2025, for an estimated $67,799,314
- FMR LLC removed 212,708 shares (-87.7%) from their portfolio in Q3 2025, for an estimated $49,395,051
- CITADEL ADVISORS LLC added 194,872 shares (+429.5%) to their portfolio in Q2 2025, for an estimated $45,050,508
- WELLINGTON MANAGEMENT GROUP LLP removed 190,853 shares (-3.3%) from their portfolio in Q3 2025, for an estimated $44,319,883
- MARSHALL WACE, LLP removed 190,045 shares (-98.4%) from their portfolio in Q3 2025, for an estimated $44,132,249
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
